D
Drugs Made In America Acquisition II Corp. Ordinary Shares
DMII · NASDAQ · Financial Services · 645M
Price · close
$10.14
+0.00% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
32.2×
Price / net assetsP/B
0.3×
Enterprise value / EBITDAEV/EBITDA
-103.6×
Free cash flow yieldFCF yield
-0.8%
Return on equityROE
0.9%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.0×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.